Home  »  Company   »  Checkpoint Therapeutics Inc. (NASDAQ: CKPT):The St...

Checkpoint Therapeutics Inc. (NASDAQ: CKPT):The Stock Was Up 25.58 Percent From Its Lows On Friday, So What’s To Come?

During the last session, Checkpoint Therapeutics Inc. (NASDAQ:CKPT)’s traded shares were 0.47 million, with the beta value of the company hitting 1.76. At the end of the trading day, the stock’s price was $1.29, reflecting an intraday gain of 13.16% or $0.15. The 52-week high for the CKPT share is $4.64, that puts it down -259.69 from that peak though still a striking 25.58% gain since the share price plummeted to a 52-week low of $0.96. The company’s market capitalization is $121.75M, and the average intraday trading volume over the past 10 days was 0.5 million shares, and the average trade volume was 489.02K shares over the past three months.

Checkpoint Therapeutics Inc. (CKPT) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.80. CKPT has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.17.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Checkpoint Therapeutics Inc. (NASDAQ:CKPT) trade information

Checkpoint Therapeutics Inc. (CKPT) registered a 13.16% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 13.16% in intraday trading to $1.29 this Friday, 08/05/22, hitting a weekly high. The stock’s 5-day price performance is 15.18%, and it has moved by 14.16% in 30 days. Based on these gigs, the overall price performance for the year is -49.41%. The short interest in Checkpoint Therapeutics Inc. (NASDAQ:CKPT) is 3.13 million shares and it means that shorts have 7.55 day(s) to cover.

The consensus price target of analysts on Wall Street is $17.60, which implies an increase of 92.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7.00 and $26.00 respectively. As a result, CKPT is trading at a discount of -1915.5% off the target high and -442.64% off the low.

Checkpoint Therapeutics Inc. (CKPT) estimates and forecasts

Statistics show that Checkpoint Therapeutics Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Checkpoint Therapeutics Inc. (CKPT) shares have gone down -46.03% during the last six months, with a year-to-date growth rate more than the industry average at 6.67% against 1.00. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -41.70% this quarter and then drop -21.40% in the quarter after that. In the rating firms’ projections, revenue will decrease -70.10% compared to the previous financial year.

As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $110k and $29k respectively.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 6.50%. While earnings are projected to return -80.30% in 2022.

CKPT Dividends

Checkpoint Therapeutics Inc. is due to release its next quarterly earnings between March 07 and March 11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Checkpoint Therapeutics Inc. (NASDAQ:CKPT)’s Major holders

Checkpoint Therapeutics Inc. insiders own 15.50% of total outstanding shares while institutional holders control 14.89%, with the float percentage being 17.62%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 83 institutions own stock in it. As of Mar 30, 2022, the company held over 3.02 million shares (or 10.46% of all shares), a total value of $5.34 million in shares.

The next largest institutional holding, with 1.14 million shares, is of MORGAN JESS S & CO INC’s that is approximately 3.94% of outstanding shares. At the market price on Jun 29, 2022, these shares were valued at $1.17 million.

Also, the Mutual Funds coming in first place with the largest holdings of Checkpoint Therapeutics Inc. (CKPT) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Mar 30, 2022 indicates that Vanguard Total Stock Market Index Fund owns about 1.98 million shares. This amounts to just over 6.85 percent of the company’s overall shares, with a $3.5 million market value. The same data shows that the other fund manager holds slightly less at 0.86 million, or about 2.98% of the stock, which is worth about $1.52 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]